Objective: To ensure informed family planning including use of advanced therapies during pregnancy. Regular follow-up during the preconception period and pregnancy to provide education, counselling, and disease optimization to improve materno-fetal outcomes are recommended. |
Patient population: Individuals (male and female) with a known diagnosis of IBD who are of reproductive age. |
Highlight BoxOptimization of maternal and neonatal outcomes in IBD begins before conception.
Women should be advised that they should be more concerned about the effect of active inflammation rather than the effects of active medications. Ongoing medical therapy to maintain disease control is paramount. Almost all IBD medications (with the exception of methotrexate and the oral small molecules, that is the JAK inhibitors or S1P modulators) are safe during pregnancy and breast-feeding. A hiatus in therapy is not recommended and individuals should be treated through pregnancy and breastfeeding. |
Patients with IBD and their health care providers often have questions regarding the interaction of IBD with fertility, pregnancy, breast feeding, and infant health. Although the management of IBD continues to evolve as newer IBD therapies become available, the core discussion points for education/counselling and for IBD management in the preconception or pregnant IBD patient remain consistent. This CCP provides guidance on the key principles to discuss and to implement with your IBD patients in the preconception and pregnancy timepoints.
Family planning - Does the patient think he/she might want to have children? If the patient does not want to have children, an additional question about the factors leading up to their decision is encouraged as patients may be misinformed about genetic, disease or medication risks.
Modifiable risk factors for good maternal and infant outcomes during pregnancy – Encourage smoking cessation, healthy diet, prenatal multivitamin intake and disease control. Be more concerned about active disease than active medications!
Non modifiable risk factors for the development of IBD in the infant – genetic risk is considered minor. Focus on what can be modified!
If a patient is in clinical remission, fertility is similar to that of the general population. Active IBD or a history of pelvic surgery (including proctectomy or an ileal pouch anal anastomosis) can decrease fertility.
1. Commence a prenatal multivitamin (containing iron and folate – minimum 0.5mg/day but 2mg/day if on sulfasalazine). Check ferritin, vitamin B12 and vitamin D and provide appropriate supplementation.
2. Evaluate disease activity with clinical assessment, fecal calprotectin +/- endoscopy/imaging to ensure disease remission prior to attempting conception. This is relevant even in asymptomatic individuals as symptoms may not correlate with disease activity.
3. If IBD is controlled, but still unable to conceive after 12 months of active trying, consider referral to a fertility specialist to exclude other causes of subfertility. In women who have a history of extensive pelvic surgery, e.g. an ileoanal pouch anastomosis or proctocolectomy, consider referral to a fertility specialist after 6 months of trying to conceive.
It is important to control disease activity to quiescence during pregnancy. Treating-to-target (mucosal healing) – to achieve clinical, biochemical, sonographic, and, endoscopic healing is just as important during pregnancy as in the nonpregnant state.
Routine lab work should be performed each trimester, consider fecal calprotectin in the 1st and 3rd trimesters (given that this can predict a disease flare 3-6 months ahead, and 3 months = 1 trimester), intestinal ultrasound is an excellent non-invasive tool for disease assessment and can be performed prior to 24 weeks gestation (if later, baby will steal the show and the bowel can’t be visualized adequately). Endoscopic evaluation can be considered if it will change patient management, e.g. in an acute flare when an assessment if required before initiating or changing therapy, and/or if biopsies are required to exclude viral superinfection.
The importance of disease control is evidenced by patients with active disease at time of conception being 7-8 times more likely to flare during pregnancy and 2-3 times more likely to have a preterm birth. Preterm birth characterized by delivery prior to 37 weeks gestation, increases the risk of neurodevelopmental problems and also increases the risk of infection in the infant (due to immaturity of the immune system). It is important to note that it is active disease not active treatment that increases the risk of these adverse maternal fetal outcomes.
Women with Crohn’s disease generally fare well during pregnancy and enter relative disease quiescence, however, the treat to target strategy still applies and appropriate therapy should be continued. Women with ulcerative colitis are at increased risk of a flare during the second and third trimester out to the early postpartum phase, even if they started the pregnancy in remission. Individuals with ulcerative colitis often require supplemental rectal therapy along with existing maintenance medications. As outlined in the ‘Effect of IBD on pregnancy’ all attempts should be made to maintain disease control throughout pregnancy with medical therapy.
5-ASA
Corticosteroids
Azathioprine
Biologics
Methotrexate, JAK inhibitors, Sphingosine-1-phosphate (S1P) modulators
We recommend women with IBD are followed by an obstetrician with expertise in high-risk pregnancies, or a materno-fetal medicine specialist.
Vaginal delivery is generally recommended in women with IBD. There are only limited contraindications including those with active perianal disease, extensive pelvic surgery or those with an ileal anal pouch anastomosis. Decision regarding mode of delivery is generally based on obstetric considerations including cephalo-pelvic disproportion, breech presentation etc.
Pregnant women who are hospitalised for a disease flare or for caesarean delivery should be provided thromboembolic prophylaxis with heparin.
This comprises of the following subsections: mental health, vaccinations, nutrition, cancer screening.
Mental health
Vaccinations
Nutrition
Cancer screening
IBD Parenthood Project The Parenthood Project - My IBD Life (gastro.org)
This provides excellent downloadable handouts for patients.
Crohn’s and Colitis Canada https://crohnsandcolitis.ca/Living-with-Crohn-s-Colitis/Fertility-pregnancy
Nguyen GC and Seow CH et al. The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy. Gastroenterology 2016; 150:734-757 https://doi.org/10.1053/j.gastro.2015.12.003
Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report from the American Gastroenterological Association IBD Parenthood Project Working Group. https://doi.org/10.1053/j.gastro.2018.12.022